Advertisement
Organisation › Details
UDG Healthcare (Group)
UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing over 8,500 people with operations in 26 countries and delivering services in over 50 countries. UDG Healthcare plc operates across two divisions: Ashfield and Sharp. Ashfield is a global leader in advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies. Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries, operating from state-of the-art facilities in the US and Europe. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250. *
Start | 2013-10-01 renamed | |
Group | Inizio (Group) | |
Today | Inizio (Group) | |
Predecessor | United Drug (Group) | |
Successor | Inizio (Group) | |
Industry | public relations / investor relations / marcom (services) | |
Region | Dublin | |
Country | Ireland, Republic of | |
Street | 20 Riverwalk Citywest Business Campus | |
City | D24 NR23 Dublin 24 | |
Tel | +353-1-468-9000 | |
Address record changed: 2021-03-28 | ||
Basic data | Employees | G: 5,001 to 10,000 (2020-09-30) |
Currency | USD | |
Annual sales | 1,279,194,000 (revenue, consolidated (2019/20) 2020-09-30) | |
Profit | 92,841,000 (2020-09-30) | |
Cash | 246,045,000 (2020-09-30) | |
* Document for »About Section«: UDG Healthcare plc. (11/26/19). "Press Release: UDG Healthcare Acquires U.S. Strategic Communications Agency". | ||
Record changed: 2023-11-11 |
Advertisement
More documents for Inizio (Group)
- [1] Molecure S.A.. (7/21/23). "Press Release: Molecure Completes Successful Secondary Public Offering (SPO) of approximately PLN 50 Million (USD 12 Million)". Warsaw....
- [2] Molecure S.A.. (3/30/23). "Press Release: Molecure Announces Full Year Financial 2022 Results – a Year of Significant Progress". Warsaw....
- [3] Transgene S.A.. (12/15/22). "Press Release: Transgene Announces Upcoming Investor Meetings". Strasbourg....
- [4] Inizio (trading name of CD&R Artemis Holdco 0.5 Ltd.). (6/30/22). "Press Release: Introducing Inizio. Ashfield and Huntsworth Unite Expertise to Form Powerful Strategic Partner for Health and Life Sciences Companies"....
- [5] BioCaptiva Ltd.. (4/13/22). "Press Release: BioCaptiva Appoints Alison Williamson as Chief Financial Officer and Board Director". Edinburgh....
- [6] Medistrava Consulting. (6/21/21). "Press Release: Medistrava Consulting Adds Industry Leading Strategic Communications Capability to Its International Healthcare Advisory Practice". London....
- [7] Huntsworth. (11/6/20). "Press Release: Huntsworth Expands Global Health Network with Nucleus Acquisition". London....
- [8] UDG Healthcare plc. (11/26/19). "Press Release: UDG Healthcare Acquires U.S. Strategic Communications Agency"....
- [9] Huntsworth plc. (5/30/19). "Press Release: Huntsworth plc Appoints Annabelle Sandeman as Its New Global Head of Commercial Strategy". London....
- [10] Huntsworth plc. (3/5/19). "Press Release: Audited Preliminary Results for the Year Ended 31 December 2018"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top